Subcutaneous bolus injection of deferoxamine is an alternative method to subcutaneous continuous infusion

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 1, 2006, Pages 11-16

  Yarali, Neşe ^a   Fişgin, Tunç ^b   Duru, Feride ^a   Kara, Abdurrahman ^a   Ecin, Nurhayat ^a   Fitoz, Suat ^c   Erden, Ilhan ^c  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Bolus; Children; Deferoxamine; Infusion; Thalassemia

Indexed keywords

DEFEROXAMINE; FERRITIN; IRON; SIDEROPHORE;

ADOLESCENT; ARTICLE; BACK MUSCLE; BOLUS INJECTION; CHELATION THERAPY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; ECHO PLANAR IMAGING; ELECTRON SPIN RESONANCE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPEREMIA; INFUSION PUMP; INJECTION PAIN; INJECTION SITE SWELLING; INTERMETHOD COMPARISON; IRON URINE LEVEL; LIVER; LIVER BIOPSY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGNAL DETECTION; STATISTICAL SIGNIFICANCE; THALASSEMIA; URINALYSIS; URINARY EXCRETION; BETA THALASSEMIA; BIOPSY; BLOOD; COMPARATIVE STUDY; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; BETA-THALASSEMIA; BIOPSY; CHILD; CHILD, PRESCHOOL; DEFEROXAMINE; FEMALE; FERRITINS; HUMANS; INFUSION PUMPS; INJECTIONS, SUBCUTANEOUS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; SIDEROPHORES;

EID: 33644844914     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Olivieri NF. The beta-thalassemias. N Engl J Med. 1999;341:99-109.
2. Orkin SH, Nathan DG. The thalassemias. In: Nathan DG, Orkin SG, eds. Nathan and Oski's Hematology of Infancy and Childhood, 5th ed. Philadelphia: WB Saunders, 1998:811-886.
3. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997;89:739-761.
4. Giardina PJ, Grady RW. Chelation therapy in beta-thalassemia: an optimistic update. Semin Hematol. 2001;38:360-366.
5. Hershko C, Konijn AM, Link G. Iron chelators for thalassaemia. Br J Haematol. 1998;101:399-406.
6. Borgna-Pignatti C, Cohen A. Evaluation of a new method of administration of the iron chelating agent deferoxamine. J Pediatr. 1997;130:86-88.
7. Di Gregorio F, Romeo MA, Pizzarelli G, et al. An alternative to continuous subcutaneous infusion of deferoxamine in thalassaemic patients. Br J Haematol. 1997;98:601-602.
8. Franchini M, Gandini G, de Gironcoli M, et al. Safety and efficacy of subcutaneous bolus injection of deferoxamine in adult patients with iron overload. Blood. 2000;95:2776-2779.
9. Borgna-Pignatti C, Cohen A. An alternative method of subcutaneous deferoxamine administration. Blood. 1995;86(Suppl 1):483a.
10. Borgna-Pignatti C, Franchini M, Gandini G, et al. Subcutaneous bolus injection of deferoxamine in adult patients affected by onco-hematologic diseases and iron overload. Haematologica. 1998;83:788-790.
11. Jensen PD, Jensen FT, Christensen T, et al. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. Br J Haematol. 1995;89:880-889.
12. Jensen PD, Heickendorff L, Pedersen B, et al. The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol. 1996;94:288-299.
13. Liang L, D'Haese PC, Lamberts LV, et al. Direct determination of iron in urine and serum using graphite furnace atomic absorption spectrometry. Analyst. 1989;114:143-147.
14. Bondestam S, Lamminen A, Anttila VJ, et al. Magnetic resonance imaging of transfusional hepatic iron overload. Br J Radiol. 1994;67:339-341.
15. Barry M, Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet. 1971;1:100-103.
16. Porter JB, Abeysinghe RD, Marshall L, et al. Kinetics of removal and reappearance of non-transferrin-bound plasma iron with deferoxamine therapy. Blood. 1996;88:705-713.
17. Porter JB, Srichairatanakool S, Nathan DG, et al. Relative efficacy of subcutaneous infusions and bolus injections of deferoxamine in the removal of non-transferrin-bound iron (NTBI). Blood. 1998;92(Suppl 1):668a.
18. Jensen PD, Jensen FT, Christensen T, et al. Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol. 1994;87:171-184.
19. Franchini M. Advances in iron chelating therapy. Haematologia (Budap). 2000;85:1122-1125.
20. Stark DD, Moseley ME, Bacon BR, et al. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology. 1985;154:137-142.
21. Ooi GC, Chen FE, Chan KN, et al. Qualitative and quantitative magnetic resonance imaging in haemoglobin H disease: screening for iron overload. Clin Radiol. 1999;54:98-102.
22. Bonkovsky HL, Rubin RB, Cable EE, et al. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology. 1999;212:227-234.
23. Telfer PT, Prestcott E, Holden S, et al. Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol. 2000;110:971-977.
24. Mazza P, Giua R, De Marco S, et al. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver. Haematologica. 1995;80:398-404.
25. Angelucci E, Baronciani D, Lucarelli G, et al. Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsies. Br J Haematol. 1995;89:757-761.